Among the MG patients included in this analysis of CD4+ T cells, eight were newly diagnosed at the time of blood sampling, referred to here as “first visits”, while the remaining samples were obtained during follow-up visits approximately every three months (Table 1). The gene discussed is CD4; the disease is myasthenia gravis.